Monitoring cardiovascular rehabilitation outcomes in Switzerland
Swiss Secondary Prevention and Rehabilitation Registry: SwissPR
University Hospital, Basel, Switzerland · NCT05500859
This study looks at how a 12-week heart rehabilitation program in Switzerland affects patients' heart health and helps identify those at higher risk for heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Basel, Switzerland (other) |
| Locations | 1 site (Basel) |
| Trial ID | NCT05500859 on ClinicalTrials.gov |
What this trial studies
The SwissPR study is a longitudinal observational cohort study that aims to monitor patient characteristics and benchmark quality measures for individuals participating in a 12-week ambulatory cardiac rehabilitation program at the University Hospital Basel. It includes both retrospective and prospective data collection to assess the impact of the rehabilitation program on cardiovascular health outcomes. The study seeks to identify patients at higher cardiovascular risk and understand the factors influencing secondary prevention behaviors. By creating a comprehensive registry, the study addresses the lack of data on the Swiss population's experiences during and after cardiac rehabilitation.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals of all age groups who are participating in an ambulatory cardiac rehabilitation program and can provide informed consent.
Not a fit: Patients who are unable to follow an ambulatory cardiac rehabilitation program for more than three weeks or who cannot provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the quality of cardiac rehabilitation programs and enhance patient outcomes for those with cardiovascular diseases.
How similar studies have performed: Other studies have shown success in monitoring rehabilitation outcomes, but this specific registry approach is novel for the Swiss population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participation in an ambulatory CR program (all age groups) * Written informed consent Exclusion Criteria: * Inability to follow an ambulatory CR program more than 3 weeks * Not willing to give informed consent * Inability to understand the informed consent due to language comprehension * Lack of discernment
Where this trial is running
Basel
- University Hospital Basel, Division of Outpatient Cardiology — Basel, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Otmar Pfister, Prof. Dr. med. — Outpatient Cardiology, University Hospital Basel
- Study coordinator: Otmar Pfister, Prof. Dr. med.
- Email: otmar.pfister@usb.ch
- Phone: +41 61 328 7482
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases, Coronary artery disease, Cardiac rehabilitation, Acute coronary syndrome, Chronic coronary syndrome, Prevention benchmark performance measures, KARAMBA, Swiss Prevention and Rehabilitation Registry